Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Paolo Guanciali Franchi is active.

Publication


Featured researches published by Paolo Guanciali Franchi.


Human Genetics | 1998

A quarter of men with idiopathic oligo-azoospermia display chromosomal abnormalities and microdeletions of different types in interval 6 of Yq11.

Liborio Stuppia; Valentina Gatta; Giuseppe Calabrese; Paolo Guanciali Franchi; Elisena Morizio; Cristina Bombieri; Rita Mingarelli; Vincenzo Sforza; Giovanni Vanni Frajese; Raffaele Tenaglia; Giandomenico Palka

Cytogenetic investigations and molecular analysis of the Y chromosome by the polymerase chain reaction amplification of sequence-tagged sites (STS-PCR) technique were performed in 126 patients affected by idiopathic oligo-azoospermia following accurate selection of cases. Seventeen patients evidenced an abnormal karyotype. Fourteen patients with a normal karyotype had microdeletions of the Y chromosome within interval 6. In azo-ospermic patients microdeletions were scattered along different subintervals, while in oligozoospermic patients they were clustered in subinterval 6E. The size of the deletion was not apparently related to the severity of the disease. These results suggest that cytogenetic analysis and the STS-PCR technique can detect a genetic cause of infertility in about one-quarter of patients with idiopathic oligo-azoospermia.


Cancer Genetics and Cytogenetics | 1994

Complex translocations of the Ph chromosome and Ph negative CML arise from similar mechanisms, as evidenced by FISH analysis

G. Calabrese; Liborio Stuppia; Paolo Guanciali Franchi; Rita Peila; Elisena Morizio; Anna Maria Liberati; Antonio Spadano; Roberto Di Lorenzo; Emilio Donti; Adriano Antonucci; Giandomenico Palka

The authors report on 13 patients with chronic myeloid leukemia (CML) studied by serial karyotyping and fluorescence in situ hybridization (FISH) of their bone marrow cells. Ten patients had complex translocations of the Ph chromosome while the remaining three were Ph negative. FISH analysis revealed in all 13 patients the translocation of the ABL protooncogene into chromosome 22 at band q11. Moreover, in all complex translocations but one, FISH with a chromosome 22 painting probe demonstrated on one chromosome 9 at band q34 the presence of material from chromosome 22, in addition to signals on the third chromosome involved in complex changes. Therefore, in this study complex translocations appeared as secondary changes resulting from two consecutive translocations with a total of at least four breaks. The first translocation gave rise to the standard t(9;22)(q34;q11). The second one included a break distal to the original breakpoint at band 9q34 and another one on a third chromosome. Furthermore FISH using S1 and S15 probes, mapped at band 22q11.2 or 22q12, gave evidence that in complex translocations the secondary breakpoint on der(9) was in the translocated segment 22q11-qter between bands q11 and q12. FISH analysis also disclosed the presence of material from chromosome 22 on one chromosome 9 in the three patients with Ph negative CML, demonstrating that in these cases a retranslocation between chromosomes 9q+ and 22q- had occurred. Consequently, the four-break mechanism could also be invoked for the three Ph negative CML patients.


Pediatrics | 2012

Mosaic 7q31 deletion involving FOXP2 gene associated with language impairment.

Chiara Palka; Melissa Alfonsi; Angelika Mohn; Renato Cerbo; Paolo Guanciali Franchi; Donatella Fantasia; Elisena Morizio; Liborio Stuppia; Giuseppe Calabrese; Roberto T. Zori; Francesco Chiarelli; Giandomenico Palka

We report on a 10-year-old patient with childhood apraxia of speech (CAS) and mild dysmorphic features. Although multiple karyotypes were reported as normal, a bacterial artificial chromosome array comparative genomic hybridization revealed the presence of a de novo 14.8-Mb mosaic deletion of chromosome 7q31. The deleted region involved several genes, including FOXP2, which has been associated with CAS. Interestingly, the deletion reported here was observed in about 50% of cells, which is the first case of mosaicism in a 7q31 deletion. Despite the presence of the deletion in only 50% of cells, the phenotype of the patient was not milder than other published cases. To date, 6 cases with a deletion of 9.1-20 Mb involving the FOXP2 gene have been reported, suggesting a new contiguous gene deletion syndrome characterized mainly by CAS caused by haploinsufficiency of the genes encompassed in the 7q critical region. This report suggests that children found with a deletion involving the FOXP2 region should be evaluated for CAS and that analysis of the FOXP2 gene including array comparative genomic hybridization should be considered in selected patients with CAS. Mosaic deletions in this area may also be considered as causative of CAS.


Human Genetics | 1996

Molecular studies in three patients with isodicentric Y chromosome

Liborio Stuppia; Giuseppe Calabrese; Paolo Guanciali Franchi; Rita Mingarelli; Elisena Morizio; Giuseppe Sabatino; Giandomenico Palka

Abstract Three patients carrying an isodicentric (idic) Y chromosome associated with a mosaic 45,X cell line were studied using molecular techniques. Genotype-phenotype correlations suggested an effect of the 45,X cell line on sexual differentiation. A relationship was established between instability of the idic(Y) chromosome and localization of the breakpoint on Yq, and between azoospermia and deletion of interval 6 on Yq.


Cancer Genetics and Cytogenetics | 1991

Cytogenetic survey of 31 patients treated with bone marrow transplantation for acute nonlymphocytic and acute lymphoblastic leukemias

Giandomenico Palka; Giuseppe Calabrese; Gabriele Di Girolamo; Liborio Stuppia; Paolo Di Bartolomeo; Paolo Guanciali Franchi; Clemente Di Virgilio; Grace Patrizia Bianchi; Francesco Angrilli; Giustino Parruti; G. Torlontano

The authors report on a sequential cytogenetic study carried out on 31 patients with acute leukemia (20 with acute lymphoblastic leukemia and 11 with acute non-lymphocytic leukemia) who underwent bone marrow transplantation (BMT). Engraftment was documented in all patients with sex-mismatched donors and with donor constitutional aberrations. During the follow-up, ranging from 6 to 110 months, clinical and hematologic relapse was observed in 11 patients (35.5%). Five of these cases showed a normal karyotype, 3 were of undefined relapse origin, 2 were aneuploid karyotypes, and one was donor (male) metaphases. Cytogenetic and immunologic data in the latter patient were suggestive of relapse in donor cells.


Cancer Genetics and Cytogenetics | 1989

Cytogenetics in patients with chronic myelogenous leukemia treated with bone marrow transplantation

G. Calabrese; Paolo Di Bartolomeo; Liborio Stuppia; Paolo Guanciali Franchi; Giustino Parruti; Marina Ciancarelli; Francesco Angrilli; Leonardo Geraci; Giandomenico Palka

Cytogenetic data are reported from 16 patients with Philadelphia chromosome (Ph) positive chronic myelogenous leukemia (CML) treated with bone marrow transplantation (BMT). The usefulness of cytogenetic investigations for the assessment of marrow engraftment is stressed. The significance of persistence or reappearance of Ph after BMT, possibly due to a defective leukemic clone eradication by the conditioning regimen, is also discussed. Generally, Ph-positive cells are damaged and disappear within the first year of BMT. Sometimes, however, the cells may repair the damage and proliferate again, resulting in disease relapse. Rarely, clinical and hematologic relapse does not follow Ph-positive clone expansion although leukemic cells represent more than 50% of marrow metaphases examined. Finally, the effect of interferon on Ph-positive clones after BMT and random chromosome changes, that appear transiently after BMT and are of uncertain significance, are discussed.


Cancer Genetics and Cytogenetics | 1993

Detection of minimal residual disease by polymerase chain reaction in patients with different hematologic diseases treated by bone marrow transplantation

Liborio Stuppia; G. Calabrese; Paolo Guanciali Franchi; Paolo Di Bartolomeo; Adriano Antonucci; Rita Peila; G. Torlontano; Giandomenico Palka

Thirteen male patients affected by different hematologic diseases who underwent bone marrow transplantation (BMT) with female donors were investigated by cytogenetic analysis and polymerase chain reaction (PCR) amplification of a DNA sequence specific for the Y chromosome. In six of these patients, PCR showed the presence of the Y chromosome-related sequence; in only three of these did cytogenetic analysis confirm the presence of mixed chimerism. In the remaining three patients, the results of the PCR were confirmed by in situ hybridization on cell nuclei with a probe for the alpha-satellite of the Y chromosome. We compare results obtained with the two methods and discuss the meaning of the minimal residual disease detected by PCR in patients submitted to BMT.


Bone Marrow Transplantation | 2000

Spectral karyotyping (SKY) refinement of a complex karyotype with t(20;21) in a Ph-positive CML patient submitted to peripheral blood stem cell transplantation

Giuseppe Calabrese; Donatella Fantasia; Paolo Guanciali Franchi; Elisena Morizio; L. Stuppia; Valentina Gatta; P Olioso; Rita Mingarelli; A Spadano; Giandomenico Palka

A patient with a Ph-positive chronic myeloid leukaemia (CML) was submitted to allogeneic peripheral blood stem cell transplantation from an HLA-haploidentical related donor 7 years after the diagnosis. Six months later, he showed a disease relapse while cytogenetic analysis displayed a complex karyotype. To characterise the chromosomal rearrangements spectral karyotype (SKY) analysis was used. This redefined all chromosome rearrangements and revealed a t(20;21)(q11;q22). FISH analysis with a specific probe for the AML1 gene disclosed disruption of this gene which was partially translocated on to the long arm of chromosome 20. It is likely that this rearrangement, unusual for CML, was implicated in the disease evolution towards blastic crisis (BC). Bone Marrow Transplantation (2000) 26, 1125–1127.


British Journal of Haematology | 2003

Chromosome 11 rearrangements and specific MLL amplification revealed by spectral karyotyping in a patient with refractory anaemia with excess of blasts (RAEB).

Giuseppe Calabrese; Donatella Fantasia; Elisena Morizio; Patrizia Marani Toro; Paolo Guanciali Franchi; Antonella Fornaro; Antonio Spadano; Liborio Stuppia; Giandomenico Palka

Summary. A patient with refractory anaemia with excess of blasts (RAEB) had a complex karyotype with multiple markers. Spectral karyotyping (SKY) showed rearrangements including three different der(11), containing a very high number of MLL gene copies, shown by fluorescence in situ hybridization (FISH) analysis. Fibre‐FISH experiments disclosed the presence of chromatin fibres with multiple MLL copies with a head‐to‐tail pattern. Apparently, no other region flanking the MLL site was present in the three der(11). MLL amplification was confirmed by the reverse transcription polymerase chain reaction (RT‐PCR). The patient died 6 months after diagnosis, supporting the severe prognosis of sole MLL amplification.


Cancer Genetics and Cytogenetics | 1995

Retrospective investigation of hematopoietic chimerism after BMT by PCR amplification of hypervariable DNA regions

Liborio Stuppia; Giuseppe Calabrese; Paolo Di Bartolomeo; Rita Peila; Paolo Guanciali Franchi; Elisena Morizio; Giandomenico Palka

We report on nine patients submitted to BMT with sex-matched donors and investigated by means of PCR amplification of the VNTRs ApoB, D1S80, DXS52, and D17S5. In all cases it was possible to detect a polymorphism able to distinguish between donor and patient cells, thus allowing us to recognize the presence of complete or mixed chimerism. In eight patients PCR analysis showed a complete chimerism during the entire follow-up. Only one of these patients relapsed, while the others are alive and without any sign of relapse 56.2 months (mean) after BMT. Mixed chimerism was detected in only one patient, who relapsed 3 months after this finding. These results confirm the usefulness of the study of PCR-amplified VNTRs in the assessment of marrow engraftment after BMT, mostly in sex-matched transplants where, in the absence of specific chromosome rearrangements, cytogenetic or FISH analysis cannot be used.

Collaboration


Dive into the Paolo Guanciali Franchi's collaboration.

Top Co-Authors

Avatar

Giandomenico Palka

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Liborio Stuppia

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Giuseppe Calabrese

University of Modena and Reggio Emilia

View shared research outputs
Top Co-Authors

Avatar

Elisena Morizio

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Adriano Antonucci

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

G. Calabrese

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Antonio Spadano

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

G. Torlontano

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Giustino Parruti

University of Chieti-Pescara

View shared research outputs
Top Co-Authors

Avatar

Paolo Di Bartolomeo

University of Chieti-Pescara

View shared research outputs
Researchain Logo
Decentralizing Knowledge